European Drug Report 2017

Author (Corporate)
Publication Date 06/06/2017
Content Type ,

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions were explored in EMCDDA's annual overview of the European drug situation European Drug Report 2017 published on the 6 June 2017.

The European Drug Report 2017: Trends and Developments, provides a comprehensive analysis of the latest tendencies across the 28 EU Member States, Turkey and Norway. The report examines: drug supply and the market; drug use prevalence and trends; and drug-related harms and responses to them.

Accompanying the report was the 2017 Statistical Bulletin, containing the European dataset underpinning the analysis.

The report was complemented for the first time by 30 Country Drug Reports, presenting summaries of national drug phenomena (EU 28, Turkey and Norway). Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

Source Link
Related Links
EU Bookshop: Find EMCDDA publications through EU Bookshop
ESO: Background information: EU Drug Markets Report 2016
Deutsche Welle, 06.06.17: New report highlights concern over rising drug-related deaths in Europe
The Guardian, 06.06.17: Almost one in three drugs overdoses in Europe recorded in UK
EUObserver, 07.06.17: Drug overdoses on the rise in Europe

Subject Categories
Countries / Regions